Last updated: August 28, 2023
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Carpal Tunnel Syndrome
Treatment
FSN
wrist splinting
Clinical Study ID
NCT05627349
CMUH111-REC2-065
Ages 20-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Male or female aged 20-85 years old.
- Meet the diagnosis of mild to moderate carpal tunnel syndrome.
- If the patient has carpal tunnel syndrome in both hands, choose the side with mild ormoderate carpal tunnel syndrome.
- After being explained, join the trial voluntarily and sign the subject's consent form.
Exclusion
Exclusion Criteria:
- Caused by trauma or mass lesion.
- Thenar muscle atrophy.
- Electrophysiological examination revealed severe CTS.
- Chronic kidney disease, rheumatoid arthritis, abnormal thyroid function, diabetes.
- Psychiatric history or incapable of cooperating with the investigator.
- Pregnancy.
- History of substance abuse or long-term steroid use.
- History of median nerve surgery.
- Those who do not sign the consent form.
Study Design
Total Participants: 60
Treatment Group(s): 2
Primary Treatment: FSN
Phase:
Study Start date:
August 20, 2023
Estimated Completion Date:
June 20, 2025
Connect with a study center
China Medical University Hsinchu Hospital
Zhubei, Hsinchu County 302
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.